No abstract

The urodynamic investigation at hand showed urinary tract dysfunction in 78 of 100 MS patients with lower urinary tract symptoms (LUTS). The long latency between the occurrence of MS and/or the beginning of LUTS and the first neuro-urological evaluation indicates a deficit in treatment. Beyond national guidelines, all MS patients should at regular intervals be questioned about LUTS and receive urodynamic assessment especially according to the presented risk profile.

The morphological findings point to outstandingly good biocompatibility of SIS. During healing the material is incorporated into the body without any foreign body or inflammatory reaction. The results of the first histological investigation of SIS in human subjects emphasize the special status of SIS among implant materials.

No abstract